Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.

T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. (PRDMX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. (CIK 1267862) · SEC series S000002073

Share classes and tickers: PRDMX (C000005433), RPTTX (C000190557)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,570 with, 33 against, 0 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 9 FOR, 25 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)85.8%2,49393.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a112.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 155 items (6.1% of the 2,545 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
TE Connectivity plc2026-03-11An advisory vote to approve named executive officer compensation.AgainstFOR — 39 of 40 T. Rowe Price fundsAgainstPassed (calculated), 92.1% support
Cencora, Inc.2026-03-05Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers.AgainstFOR — 35 of 36 T. Rowe Price fundsAgainstApproved, 93.2% support
TechnipFMC plc2026-05-012025 U.S. Say-on-Pay for Named Executive Officers: To approve, as a non-binding advisory resolution, the Company's named executive officer compensation for the year ended December 31, 2025, as reported in the Company's Proxy Statement.AgainstFOR — 35 of 36 T. Rowe Price fundsAgainst—
The Allstate Corporation2026-05-22Advisory vote to approve the compensation of the named executives.AgainstFOR — 32 of 33 T. Rowe Price fundsAgainstPassed (calculated), 92.7% support
Monolithic Power Systems, Inc.2026-06-11Approve, on an advisory basis, the 2025 executive compensation.AgainstFOR — 32 of 33 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
TechnipFMC plc2026-05-012025 U.K. Directors' Remuneration Report: To approve, as a non-binding advisory resolution, the Company's directors' remuneration report for the year ended December 31, 2025, as reported in the Company's U.K. Annual Report and Accounts.AgainstFOR — 30 of 31 T. Rowe Price fundsAgainst—
PTC Inc.2026-02-11Advisory vote to approve the compensation of our named executive officers (say-on-pay).AgainstFOR — 30 of 31 T. Rowe Price fundsAgainst—
Ross Stores, Inc.2026-05-20Advisory vote to approve the resolution on the compensation of the named executive officers.AgainstFOR — 29 of 30 T. Rowe Price fundsAgainstPassed (calculated), 92.6% support
Natera, Inc.2026-06-11To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated.AgainstFOR — 29 of 30 T. Rowe Price fundsAgainstPassed (calculated), 78.1% support
Chipotle Mexican Grill, Inc.2026-06-11An advisory vote to approve the compensation of our executive officers as disclosed in the proxy statement ("say on pay").AgainstFOR — 29 of 30 T. Rowe Price fundsAgainstApproved, 95.3% support
Tradeweb Markets Inc.2026-05-19To approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 28 of 29 T. Rowe Price fundsAgainstApproved, 98.7% support
Tenet Healthcare Corporation2026-05-27To vote, on an advisory basis, to approve the Company's executive compensation.AgainstFOR — 28 of 29 T. Rowe Price fundsAgainst—
Packaging Corporation of America2026-05-12Proposal to approve our executive compensation.AgainstFOR — 26 of 27 T. Rowe Price fundsAgainst—
Carvana Co.2026-05-05Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement.ForAGAINST — 25 of 26 T. Rowe Price fundsAgainstNot approved, 3.9% support
Datadog, Inc.2026-06-15Advisory vote to approve the compensation of our named executive officers.AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 95.9% support
Ulta Beauty, Inc.2026-06-09Advisory resolution to approve the Company's executive compensation.AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 77.9% support
Equifax Inc.2026-05-07Advisory vote to approve named executive officer compensation ("say-on-pay").AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 84.3% support
BrightSpring Health Services, Inc.2026-05-21Advisory vote on executive compensationAgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 98.7% support
Vaxcyte, Inc.2026-06-15Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 97.9% support
Hilton Worldwide Holdings Inc.2026-05-14Approval, in a non-binding advisory vote, of the compensation paid to the named executive officers.AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 92.6% support
Vertiv Holdings Co.2026-06-17To approve, on an advisory basis, the 2025 compensation of our named executive officers as disclosed in the Proxy Statement.AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 88.4% support
Quest Diagnostics Incorporated2026-05-20An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement.AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 92.4% support
HubSpot, Inc.2026-06-15Non-binding advisory vote to approve the compensation of the Company's named executive officers;AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 90.2% support
Repligen Corporation2026-05-14Election of Directors: Carrie Eglinton MannerAgainstFOR — 22 of 23 T. Rowe Price fundsAgainstElected, 81.0% support
Repligen Corporation2026-05-14Election of Directors: Glenn P. MuirAgainstFOR — 22 of 23 T. Rowe Price fundsAgainstElected, 74.4% support
Show all 155
Items 26 to 155.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Repligen Corporation2026-05-14Election of Directors: Karen A. DawesAgainstFOR — 22 of 23 T. Rowe Price fundsAgainstElected, 82.4% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: David M. CoteWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 90.4% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Edward L. MonserWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 82.9% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Giordano AlbertazziWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.5% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Jakki L. HausslerWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 96.0% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Joseph J. DeAngeloWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 74.9% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Roger FradinWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 70.3% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Steven S. ReinemundWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 76.6% support
Cheniere Energy, Inc.2026-05-14Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2025.AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstPassed (calculated), 90.7% support
Ventas, Inc.2026-05-13Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc.AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstPassed (calculated), 91.7% support
Quest Diagnostics Incorporated2026-05-20Shareholder Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting.ForAGAINST — 20 of 21 T. Rowe Price fundsAgainstNot approved, 25.6% support
Broadridge Financial Solutions, Inc.2025-11-13Advisory vote to approve the compensation of the Company's Named Executive Officers (the Say on Pay Vote);AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstPassed (calculated), 91.6% support
Elanco Animal Health Incorporated2026-05-21Advisory vote on the compensation of the company's named executive officers.AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstApproved, 82.0% support
Tractor Supply Company2026-05-14To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay)AgainstFOR — 19 of 20 T. Rowe Price fundsAgainstApproved, 86.0% support
Burlington Stores, Inc.2026-05-19Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers ("Say-On-Pay")AgainstFOR — 19 of 20 T. Rowe Price fundsAgainstPassed (calculated), 88.0% support
Howmet Aerospace Inc.2026-05-19Advisory vote to approve executive compensation.AgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 71.1% support
Cardinal Health, Inc.2025-11-05To approve, on a non-binding advisory basis, the compensation of our named executive officersAgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 90.7% support
MSCI Inc.2026-04-21To approve, by advisory vote, our executive compensation.AgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 93.6% support
Charles River Laboratories International, Inc.2026-05-05Advisory Approval of 2025 Executive Officer CompensationAgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 93.8% support
RBC Bearings Incorporated2025-09-04To consider a resolution regarding the stockholder advisory vote on named executive officer compensation.AgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 81.1% support
CBRE Group, Inc.2026-05-21Advisory vote to approve named executive officer compensation for 2025.AgainstFOR — 17 of 18 T. Rowe Price fundsAgainst—
Revolution Medicines, Inc.2026-06-18To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").AgainstFOR — 17 of 18 T. Rowe Price fundsAgainstApproved, 96.5% support
Insmed Incorporated2026-05-13An advisory vote on the 2025 compensation of our named executive officers.AgainstFOR — 17 of 18 T. Rowe Price fundsAgainstApproved, 87.3% support
Paylocity Holding Corporation2025-12-04Advisory vote to approve the compensation of named executive officers.AgainstFOR — 17 of 18 T. Rowe Price fundsAgainstPassed (calculated), 93.3% support
The Bank of New York Mellon Corporation2026-04-14Advisory resolution to approve the 2025 compensation of our named executive officers.AgainstFOR — 16 of 17 T. Rowe Price fundsAgainstPassed (calculated), 55.6% support
Alnylam Pharmaceuticals, Inc.2026-05-20To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.AgainstFOR — 16 of 17 T. Rowe Price fundsAgainst—
Westinghouse Air Brake Technologies Corporation2026-05-12Approve an advisory (non-binding) resolution to approve the 2025 named executive officer compensation.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 92.3% support
Live Nation Entertainment, Inc.2026-06-11To hold an advisory vote on the company's executive compensation;AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstPassed (calculated), 86.8% support
Rockwell Automation, Inc.2026-02-10To approve, on an advisory basis, the compensation of the Corporation's named executive officers.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 87.2% support
United Therapeutics Corporation2026-06-26Advisory resolution to approve executive compensation.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstPassed (calculated), 97.1% support
Invesco Ltd.2026-05-21Advisory vote to approve the company's 2025 executive compensation.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 98.6% support
SiTime Corporation2026-05-29To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 82.1% support
Veeva Systems Inc.2026-06-17To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon RitterAgainstFOR — 14 of 15 T. Rowe Price fundsAgainstElected, 73.6% support
Veeva Systems Inc.2026-06-17To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark CargesAgainstFOR — 14 of 15 T. Rowe Price fundsAgainstElected, 80.0% support
MongoDB, Inc.2026-06-30Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainstApproved, 89.2% support
UL Solutions Inc.2026-05-20The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainstPassed (calculated), 99.9% support
Dynatrace, Inc.2025-08-20Non-binding advisory vote on the compensation of Dynatrace's named executive officers.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainstApproved, 91.6% support
Targa Resources Corp.2026-05-21To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025.AgainstFOR — 13 of 14 T. Rowe Price fundsAgainstApproved, 95.3% support
Mueller Industries, Inc.2026-05-07To approve, on an advisory basis by non-binding vote, executive compensation.AgainstFOR — 13 of 14 T. Rowe Price fundsAgainstApproved, 95.3% support
eBay Inc.2026-06-17Advisory vote to approve named executive officer compensation.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 88.1% support
Ferguson Enterprises Inc.2026-04-30To approve, on an advisory basis, the compensation of the Company's Named Executive Officers for the five-month transition period from August 1, 2025 to December 31, 2025.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 92.4% support
United Airlines Holdings, Inc.2026-05-19A vote to approve, on a nonbinding advisory basis, the compensation of our named executive officers.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 94.3% support
Samsara Inc.2025-07-29The approval, on a non-binding advisory basis, of the compensation of Samsara Inc.'s named executive officers.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 98.6% support
United Therapeutics Corporation2026-06-26Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 72.0% support
Permian Resources Corporation2026-05-19To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 71.8% support
BJ's Wholesale Club Holdings, Inc.2026-06-18Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 93.0% support
BWX Technologies, Inc.2026-04-30Advisory vote on compensation of our Named Executive Officers.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 98.5% support
IDEXX Laboratories, Inc.2026-05-12Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).AgainstFOR — 11 of 12 T. Rowe Price fundsAgainst—
Vistra Corp.2026-04-29To approve, on a non-binding advisory basis, the 2025 compensation of the Company's named executive officers.AgainstFOR — 11 of 12 T. Rowe Price fundsAgainstApproved, 96.9% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Catherine JohnsonWithholdFOR — 20 of 24 T. Rowe Price fundsAgainstElected, 97.4% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Daniel MaguireWithholdFOR — 20 of 24 T. Rowe Price fundsAgainstElected, 97.4% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Scott GanelesWithholdFOR — 20 of 24 T. Rowe Price fundsAgainstElected, 96.9% support
Royal Caribbean Cruises Ltd.2026-05-28Advisory approval of the Company's compensation of its named executive officers.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
Quanta Services, Inc.2026-05-21Approval, by non-binding advisory vote, of the compensation of Quanta's named executive officers for fiscal year 2025;AgainstFOR — 10 of 11 T. Rowe Price fundsAgainst—
Everpure, Inc.2026-06-10An advisory vote on our named executive officer compensation.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstApproved, 90.4% support
Tapestry, Inc.2025-11-13Advisory vote to approve the Company's executive compensation, as discussed and described in the proxy statement.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstPassed (calculated), 89.9% support
Nutanix, Inc.2025-12-12Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstApproved, 92.1% support
Fair Isaac Corporation2026-03-04To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the proxy statement.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstApproved, 84.9% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Matthew LouieWithholdFOR — 18 of 22 T. Rowe Price fundsAgainstPassed (calculated), 85.6% support
Roblox Corporation2026-05-28Advisory Vote on the Compensation of our Named Executive Officers.AgainstFOR — 12 of 14 T. Rowe Price fundsAgainstPassed (calculated), 84.2% support
NRG Energy, Inc.2026-04-30To approve, on a non-binding advisory basis, NRG Energy, Inc.'s executive compensation.AgainstFOR — 9 of 10 T. Rowe Price fundsAgainst—
Insulet Corporation2026-05-20To approve, on a non-binding, advisory basis, the compensation of certain executive officers.AgainstFOR — 9 of 10 T. Rowe Price fundsAgainstPassed (calculated), 92.0% support
Corpay, Inc.2026-05-07Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting.ForAGAINST — 15 of 19 T. Rowe Price fundsAgainstFailed (calculated), 30.0% support
GoDaddy Inc.2026-06-03Company Proposal - Advisory, non-binding vote to approve named executive officer compensationAgainstFOR — 5 of 5 T. Rowe Price fundsAgainstApproved, 92.4% support
Flutter Entertainment plc2026-05-29Approval, on an advisory basis, of the compensation of our Named Executive Officers.AgainstFOR — 5 of 5 T. Rowe Price fundsAgainstApproved, 88.0% support
SharkNinja, Inc.2026-06-18To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 92.6% support
CDW Corporation2026-05-21To approve, on an advisory basis, named executive officer compensation.AgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 91.1% support
Manhattan Associates, Inc.2026-05-14Non-binding resolution to approve the compensation of the Company's named executive officers.AgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 89.5% support
Procore Technologies, Inc.2026-06-04To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officersAgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 63.1% support
Ameriprise Financial, Inc.2026-04-29To approve the compensation of the named executive officers by a nonbinding advisory vote.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstApproved, 90.6% support
Take-Two Interactive Software, Inc.2025-09-18Approval of an amendment and restatement of the Amended and Restated Take-Two Interactive Software, Inc. 2017 Stock Incentive Plan.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstApproved, 77.6% support
Interactive Brokers Group, Inc.2026-04-23To approve, by non-binding vote, executive compensation.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstPassed (calculated), 98.1% support
Medpace Holdings, Inc.2026-05-15To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainst—
Stifel Financial Corp.2026-06-09To approve, on an advisory basis, the compensation of our named executive officers (say on pay).AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstPassed (calculated), 98.1% support
Lazard, Inc.2026-05-21Approval of the amendment to the Lazard Inc. 2018 Incentive Compensation Plan.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstPassed (calculated), 60.9% support
Stride, Inc.2025-12-04Approval, on a non-binding advisory basis, of the compensation of the named executive officers of the Company;AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstApproved, 81.9% support
UL Solutions Inc.2026-05-20Election of Directors: Elisabeth TorstadWithholdFOR — 10 of 13 T. Rowe Price fundsAgainst—
UL Solutions Inc.2026-05-20Election of Directors: George A. WilliamsWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.7% support
UL Solutions Inc.2026-05-20Election of Directors: James M. ShannonWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: James P. DolliveWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.6% support
UL Solutions Inc.2026-05-20Election of Directors: Marla C. GottschalkWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: Sally SusmanWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.9% support
DexCom, Inc.2026-05-27To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025.AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 88.3% support
Williams-Sonoma, Inc.2026-06-18An advisory vote to approve executive compensationAgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 84.0% support
Rocket Lab Corporation2026-05-20Election of Class II Director Nominee: To be elected for term expiring in 2029: Edward H. FrankForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 84.2% support
CDW Corporation2026-05-21Shareholder To consider and act upon the stockholder proposal, if properly presented at the meeting, regarding independent Board chair requirements.ForAGAINST — 6 of 7 T. Rowe Price fundsAgainstNot approved, 42.7% support
NRG Energy, Inc.2026-04-30Shareholder To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting.ForAGAINST — 6 of 7 T. Rowe Price fundsAgainstApproved, 55.6% support
CACI International Inc.2025-10-16To approve on a non-binding, advisory basis the compensation of our named executive officers;AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 94.8% support
JFrog Ltd.2026-05-20To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in the proxy statement.AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 82.0% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Caroline LevyForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 98.0% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Cheryl MillerForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 98.8% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Damon DeSantisForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 96.5% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Hal KravitzForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 99.4% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Joyce RussellForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 97.3% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Nick CastaldoForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 97.7% support
Churchill Downs Incorporated2026-04-21To approve, on a non-binding advisory basis, the Company's executive compensation as disclosed in the proxy statement.AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 84.7% support
Seagate Technology Holdings plc2025-10-25Approve, in an Advisory, Non-binding Vote, the Compensation of the Company's Named Executive Officers ("Say-on-Pay").AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
BeOne Medicines Ltd.2026-06-11THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 94.9% support
Iron Mountain Incorporated2026-05-07The approval of a non-binding, advisory resolution approving the compensation of our named executive officers as described in the Iron Mountain Incorporated Proxy Statement.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 96.7% support
Expedia Group, Inc.2026-06-17Approval, on an advisory basis, of the compensation of Expedia Group's named executive officers.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 89.4% support
Twilio Inc.2026-06-16To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 93.7% support
Celestica Inc.2026-05-19To approve, on an advisory basis, the compensation of Celestica Inc.'s named executive officers.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstPassed (calculated), 96.4% support
Stifel Financial Corp.2026-06-09To approve the adoption of an amendment to the Stifel Financial Corp. 2001 Incentive Stock Plan (2018 Restatement)AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstPassed (calculated), 69.2% support
Service Corporation International2026-05-06Election of Directors: Marcus A. WattsForAGAINST — 12 of 18 T. Rowe Price fundsForFailed (calculated), 43.5% support
Service Corporation International2026-05-06To approve the 2026 Equity Incentive Plan.AgainstFOR — 12 of 18 T. Rowe Price fundsAgainstApproved, 78.1% support
Rocket Companies, Inc.2026-06-10Election of Class III Directors: Varun KrishnaWithholdFOR — 11 of 18 T. Rowe Price fundsAgainstPassed (calculated), 87.9% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Adolfo HenriquesForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 97.5% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Carol F. FineForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 98.8% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Dr. Alan SchriesheimForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 73.2% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Julie NeitzelForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 98.4% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Mark H. HildebrandtForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 73.7% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Thomas M. CulliganForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 98.3% support
BeOne Medicines Ltd.2026-06-11THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstElected, 98.8% support
BeOne Medicines Ltd.2026-06-11THAT, on an advisory basis, the Swiss Statutory Compensation Report for the fiscal year ended December 31, 2025 be and is hereby approved.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 95.6% support
BeOne Medicines Ltd.2026-06-11THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting, be and is hereby approved.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 95.4% support
Carnival Corporation2026-04-17To hold a (non-binding) advisory vote to approve executive compensation.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
Okta, Inc.2026-06-18To approve an amendment to our 2017 Equity Incentive Plan.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 70.6% support
Hyatt Hotels Corporation2026-05-20Approval, on an advisory basis, of the compensation paid to our named executive officers as disclosed pursuant to the Securities and Exchange Commission's compensation disclosure rules.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 99.5% support
Somnigroup International, Inc.2026-05-13ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; ANDAgainstFOR — 4 of 5 T. Rowe Price fundsAgainstPassed (calculated), 58.1% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 91.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 95.6% support
Domino's Pizza, Inc.2026-04-21Shareholder Shareholder proposal regarding an independent board chair requirement.ForAGAINST — 7 of 12 T. Rowe Price fundsAgainstNot approved, 39.9% support
Fastenal Company2026-04-23Shareholder Shareholder proposal relating to an EEO-1 reporting disclosure policy, if properly presented at the annual meeting.AgainstFOR — 3 of 4 T. Rowe Price funds—Not approved, 23.0% support
Carnival Corporation2026-04-17To hold a (non-binding) advisory vote to approve the Carnival plc Directors' Remuneration Report (in accordance with legal requirements applicable to UK companies).AgainstFOR — 3 of 4 T. Rowe Price fundsAgainstPassed (calculated), 97.2% support
Hyatt Hotels Corporation2026-05-20Shareholder Stockholder proposal requesting the issuance of a report analyzing whether Hyatt could disclose its overall plastics use.AgainstFOR — 3 of 4 T. Rowe Price fundsForNot approved, 0.4% support
Core & Main, Inc.2026-06-23Election of Directors: Bhavani AmirthalingamForWITHHOLD — 3 of 4 T. Rowe Price fundsForElected, 95.4% support
Core & Main, Inc.2026-06-23Election of Directors: Margaret M. NewmanForWITHHOLD — 3 of 4 T. Rowe Price fundsForElected, 94.6% support
Core & Main, Inc.2026-06-23Election of Directors: Orvin T. KimbroughForWITHHOLD — 3 of 4 T. Rowe Price fundsForElected, 64.2% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiForAGAINST — 7 of 13 T. Rowe Price fundsForElected, 68.1% support
Symbotic Inc.2026-03-05To approve an advisory vote on the compensation paid to our named executive officers.AgainstFOR — 2 of 3 T. Rowe Price fundsAgainstPassed (calculated), 99.0% support

Download all 155 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 94.3% of this fund’s 2,603 such votes could be given a sector; the other 149 (5.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary747192.5%
Technology48161.2%
Industrials37210.3%
Health Care31331.0%
Finance26231.1%
Energy7500.0%
Real Estate6600.0%
Utilities5711.8%
Miscellaneous3700.0%
Consumer Staples3000.0%
Basic Materials900.0%
Telecommunications500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,8850
Audit-related2530
Say-on-Pay2440
Corporate Governance9022
Compensation810
Capital Structure430
Shareholder Rights and Defenses91
Environment or Climate66
Extraordinary Transactions50
Other Social Issues43

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Howmet Aerospace Inc.May 19, 2026$128M110
Cloudflare, Inc.June 30, 2026$120M140
Hilton Worldwide Holdings Inc.May 14, 2026$117M130
Vertiv Holdings Co.June 17, 2026$109M130
Cencora, Inc.March 5, 2026$104M130
Quanta Services, Inc.May 21, 2026$103M120
IDEXX Laboratories, Inc.May 12, 2026$87M81
Targa Resources Corp.May 21, 2026$85M60

Notable votes against management

MeetingCompanyProposalFundMgmt
May 12, 2026IDEXX Laboratories, Inc.Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposalAgainstFor
June 15, 2026Datadog, Inc.The stockholder proposal, if properly presented at the Annual Meeting, requesting the adoption of a simple majority voting provision. Shareholder proposalForAgainst
May 7, 2026Corpay, Inc.Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. Shareholder proposalForAgainst
September 17, 2025Darden Restaurants, Inc.To vote on a shareholder proposal requesting the Company disclose measurable targets for reducing greenhouse emissions. Shareholder proposalAgainstFor
June 16, 2026Block, Inc.STOCKHOLDER PROPOSAL REGARDING ESTABLISHING A BOARD-LEVEL TECHNOLOGY COMMITTEE, IF PROPERLY PRESENTED AT THE ANNUAL MEETING. Shareholder proposalAgainstFor
May 19, 2026Verisk Analytics, Inc.Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder proposalAgainstFor
January 12, 2026Zscaler, Inc.To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder proposalForAgainst
May 14, 2026Yum! Brands, Inc.Shareholder Proposal to Reduce the Percentage of Shares Required to Call a Special Meeting. Shareholder proposalAgainstFor
April 30, 2026NRG Energy, Inc.To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalForAgainst
May 5, 2026Tyler Technologies, Inc.Shareholder Proposal Regarding Political Spending. Shareholder proposalAgainstFor
May 15, 2026Medpace Holdings, Inc.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor

Search this fund’s votes by company

2,623 ballot items at 252 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. (PRDMX) voted at 252 shareholder meetings of 247 companies, on 2,623 ballot items in all. Where management made a recommendation, the fund followed it on 98.7% of the items and voted against it 33 times. Its most frequent area of disagreement was corporate governance (22 of its votes against management). It voted on 34 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (85.8% against 93.7%). It voted differently from most T. Rowe Price funds on 155 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.